Our Recommendations
New Publications
Filter
145
Featured
Recommendations
2
New Publications
3
Language
Document type
Studies & Reports
46
Fact sheets
28
Resource Platforms
26
Guidelines
13
Videos
11
Strategic & Response Plan
6
Manuals
4
Dashboards/Maps
3
Infographics
3
No document type
3
App
1
Online Courses
1
Countries / Regions
Global
39
Latin America and the Carribbean
24
Colombia
6
North America
4
Mexico
3
Chile
2
USA
2
Paraguay
2
Argentina
2
El Salvador
1
China
1
Africa
1
Germany
1
Western Pacific Region
1
Western and Central Europe
1
Uruguay
1
Spain
1
Brazil
1
Honduras
1
Authors & Publishers
Publication Years
Category
Chagas
37
Disease Prevention & Control
19
Studies & Reports
14
Vector Control
4
Guidelines
3
Information, Education and Communication (IEC)
3
NTDs & Others
3
Trachoma
2
Lymphaticfilariasis
2
Health System Strengthening
2
Leprosy
2
Women & Child Health
2
Pharmacy & Technologies
2
Communicable Diseases
1
Buruli Ulcer
1
x MEDBOX Issue Brief & Annual Reports x
1
Countries
1
Drugs & Medical Equipment
1
Capacity Building
1
Parasitology
1
Leishmaniasis
1
HIV & STI
1
Toolboxes
Information & Education Material (IEC)
39
Studies & Reports
36
Clinical Aspects & Diagnostics
25
Chagas
23
Capacity Building & Resources
17
Statistics & Facts
13
Overview, Studies & Reports
11
NTDs
5
Pharmacy
2
Public Health
2
Zoonoses
2
Strategies & Roadmaps
2
Clinical Aspects & Diagnostics
2
Clinical Aspects & Diagnostics
2
NTDs General
2
Vector control
2
Prevention & Control
2
Latin America & the Carribean
2
Reports & Studies
2
Clinical Guidelines
1
Sustainable Development Goals
1
Dengue & Chikungunya
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Information & Education Material (IEC)
1
Statistics & Facts
1
Statistics & Facts
1
Statistics & Facts
1
Studies & Reports
1
Studies & Reports
1
Videos
1
General
1
Co-Morbidities (except TB)
1
Zika
1
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Development Goals (UN/SDG) aims at ending the e...
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its fro...
Chagas is a complex, multidimensional phenomenon in which political, economic, environmental, biomedical, epidemiological, psychological, and sociocultural factors intersect. Nonetheless, the hegemonic conceptualisation has long envisioned Chagas as primarily a biomedical question, while ignoring or...
The Chagas disease data platform is founded upon a collaborative framework that aims to bring together partners including individual researchers in Chagas endemic regions, leading global research institutions, policy specialists and funders from across the globe. The theme is coordinated by a team b...
For the molecular diagnosis of Chagas disease by real-time PCR (polymerase chain reaction), optimization of diagnostic accuracy is desirable. The detection limit of real-time PCR assays for the diagnosis of Trypanosoma cruzi in human serum is affected by various influences including the choice of th...
The protozoan parasite Trypanosoma cruzi causes Chagas disease, an important public health problem throughout Latin America. Current therapeutic options are characterised by limited efficacy, long treatment regimens and frequent toxic side-effects. Advances in this area have been compromised by gaps...
About six to seven million people worldwide, mostly in Latin America, are estimated to be infected with
Trypanosoma cruzi, the parasite that causes Chagas disease (WHO data from 2021). Chagas disease is
found mainly in endemic areas of 21 Latin American countries. Chagas disease was once entirely
...
Info Chagas
What do we need to know abaout Chagas Disease? What is Chagas Disease?
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Chagas disease is increasingly reported in Latin American migrants who have settled in Europe. It has rarely been reported in the UK due to lack of testing and awareness.
Chagas disease (American trypanosomia...
Chagas disease is caused by Trypanosoma cruzi, a protozoal organism primarily transmitted by triatomine insect vectors, also known as “kissing bugs.” It is a zoonotic disease originally described by Brazilian physician Dr. Carlos Chagas in 1909 and is widespread in Latin America. Although triato...
Epidemiology
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or...
This motion graphic shows how the kissing bug transmits the Trypanosoma cruzi parasite to humans and causes Chagas disease.
Chagas disease is a tropical disease caused by a parasite called Trypansoma cruzi and is primarily spread by Triatomine bugs. It is estimated to affect 6-7 million people, mostly in Latin America, and can cause devastating chronic illness. In this video we take a look at the disease, what it is, and...
The BeatChagas platform is a tool developed by the Technical Group of Information, Education, and Communication (IEC) for Chagas Disease (TG6-IEC Chagas), part of the Chagas Disease Control Program by the World Health Organization (WHO). The purpose of this platform is to share information about the...
Human African Trypanosomiasis, also known as sleeping sickness is a devastating parasitic disease. It is a neglected tropical disease affecting communities in Africa. In this video we take a look at the disease, how it presents and and ways to control it.
Chagas disease (CD) is caused by Trypanosoma cruzi. When acquired, the
disease develops in stages. For diagnosis, laboratory confirmation is required, and an extensive assessment of the patient’s health should be performed. Treatment consists of the administration of trypanocidal drugs, which may...
This review focusses on the interactions between the etiologic agent of Chagas disease, Trypanosoma cruzi, and its triatomine vector. The flagellate mainly colonizes the intestinal tract of the insect. The effect of triatomines on trypanosomes is indicated by susceptibility and refractoriness phenom...
Chagas disease affects approximately 6 million people, mainly in Latin America. Less than 1% of affected individuals receive proper antiparasitic treatment, and current drugs are inadequate to fight the entire spectrum of the disease. Against this background, Novartis is pursuing an end-to-end appro...
American trypanosomiasis, commonly called
Chagas disease (CD), was prevalent once in rural areas
of Latin America where poverty is widespread and was
considered a silent and poorly visible disease. It
has become a global neglected tropical disease and a
significant public health th...
Coherent Market Insights has announced the addition of Chagas Disease Treatment Market 2023 Forecast Analysis by Types, Applications, Size, Share, Key Players, and Regions. a new research report to its market research archive. The Chagas Disease Treatment Market has been thoroughly researched and an...
